Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iafrate

Showing results (501-510 of 580) with videos related to

Pageof 58
Sort By:
Science Translational Medicine|November 29, 2023
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19Reza Zonozi, Lucy C Walters, Aaron Shulkin, et al.
Frontiers in Endocrinology|December 17, 2021
Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus ProposalVincenza Granata, Francesca Coppola, Roberta Grassi, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2016
Health Care Infrastructure for Financially Sustainable Clinical GenomicsJochen K Lennerz, Heather M McLaughlin, Jason M Baron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2020
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)Keith T Flaherty, Robert J Gray, Alice P Chen, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Pageof 58

Showing results (501-510 of 580) with videos related to

Sort By:
Pageof 58
Science Translational Medicine|November 29, 2023
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19Reza Zonozi, Lucy C Walters, Aaron Shulkin, et al.
Frontiers in Endocrinology|December 17, 2021
Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus ProposalVincenza Granata, Francesca Coppola, Roberta Grassi, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2016
Health Care Infrastructure for Financially Sustainable Clinical GenomicsJochen K Lennerz, Heather M McLaughlin, Jason M Baron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2020
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)Keith T Flaherty, Robert J Gray, Alice P Chen, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Pageof 58